CryoLife Reports Record Quarterly Revenues of $28...(577 177 Other medical devices ...),Health

Date:7/30/2009

,577 177 Other medical devices 72 131 143 224 ------------------ ---------------- Total products 13,918 13,280 26,863 25,260 ------------------ ---------------- Other 154 150 349 314 ------------------ ---------------- Total revenues $28,163 $27,155 $54,851 $52,723 ================== ================ Revenues: U.S. $23,579 $22,834 $46,323 $44,834 International 4,584 4,321 8,528 7,889 ------------------ ---------------- Total revenues $28,163 $27,155 $54,851 $52,723 ================== ================ June 30, December 31, 2009 2008 ----------- ------------ (Unaudited) Cash and cash equivalents and restricted securities $ 21,700 $ 17,763 Receivables, net 15,548 13,999 Deferred preservation costs 37,029 34,913 Inventories 6,621 7,077 Restricted money market funds, long-term 5,000 5,000 Total assets 130,849 125,995 Shareholders' equity 105,663 99,326 CRYOLIFE, INC. Unaudited Reconciliation
'/>"/>

SOURCE CryoLife, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Related medicine news :

1. CryoLife Announces Release Date and Teleconference Call Details for 2009 Second Quarter Financial Results
2. Department of Defense Awards CryoLife $1.7 million to Develop BioFoam Hemostatic Technology
3. CryoLife Announces Release Date and Teleconference Call Details for First Quarter 2008 Financial Results
4. William F. Northrup, III, M.D. Joins CryoLife as Vice President of Medical Relations and Education
5. Cryolife Victim Responds to Untrue Assertions of Cryolife
6. CryoLife Announces Additions to Management Team
7. Gentiva Reports Second Quarter 2009 Results
8. BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update
9. Encision Reports Profitable First Fiscal Quarter Results
10. Nutraceutical Reports Fiscal 2009 Q3 Results and Expands Share Repurchase Program
11. Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share